| dc.contributor.author | Usmani, Omar S. | |
| dc.contributor.author | Dhand, Rajiv | |
| dc.contributor.author | Lavorini, Federico | |
| dc.contributor.author | Price, David | |
| dc.date.accessioned | 2022-02-02T17:14:01Z | |
| dc.date.available | 2022-02-02T17:14:01Z | |
| dc.date.issued | 2021-09-30 | |
| dc.identifier | 196078493 | |
| dc.identifier | 8c2817b4-5227-46fd-b9c0-a14f66c49f22 | |
| dc.identifier | 85108837685 | |
| dc.identifier.citation | Usmani , O S , Dhand , R , Lavorini , F & Price , D 2021 , ' Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease ' , Mayo Clinic Proceedings , vol. 96 , no. 9 , pp. 2448-2463 . https://doi.org/10.1016/j.mayocp.2021.03.016 | en |
| dc.identifier.issn | 0025-6196 | |
| dc.identifier.other | RIS: urn:B037AF585EE80E4379581A7AE18F86F2 | |
| dc.identifier.uri | https://hdl.handle.net/2164/18022 | |
| dc.description | ACKNOWLEDGMENTS Editorial support was provided by Cindy Macpherson, PhD, of MediTech Media, UK,and was funded by Boehringer Ingelheim | en |
| dc.format.extent | 16 | |
| dc.format.extent | 3011365 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Mayo Clinic Proceedings | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R | en |
| dc.title | Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1016/j.mayocp.2021.03.016 | |
